InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Mason Michael B, Vice-Président Senior. Insider active across 1 companies, notably ELI LILLY & Co. In total, 2 reports have been recorded. The latest transaction was disclosed on 9 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
€556,3492,612 shares@ €212.99750.0001% mcap100.0% of flow
Common Stock
SEC:0000059478-22-000044·
€556,3492,612 shares@ €212.99750.0001% mcap50.0% of flow
Common Stock
SEC:0000059478-22-000044:0·
2 of 2 declarations
About Mason Michael B
Michael B. Mason is the Senior Vice President and President of Lilly Diabetes at Eli Lilly & Co. He is responsible for the strategic direction of the Lilly Diabetes division, focusing on the development and marketing of diabetes treatments. Mason plays a crucial role in product innovation and improvement, aiming to enhance patients' lives. His expertise in the pharmaceutical sector is a significant asset for Eli Lilly, contributing to its mission of improving global health.
